The Pholcodine Story

Immunology and Allergy Clinics of North America

Volumn 29, Issue 3, 2009, Pages 419-427

  Florvaag, E ^a,b   Johansson, S G O ^c,d  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaphylaxis; IgE antibodies; Neuromuscular blocking agents; Pholcodine; Suxamethonium

Indexed keywords

CODEINE; DOMESTIC CHEMICAL; GUAIFENESIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NOSCAPINE; PHOLCODINE; SOLVIPECT; SUXAMETHONIUM; TUXI; UNCLASSIFIED DRUG;

ANAPHYLAXIS; BLOOD BRAIN BARRIER; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG SENSITIZATION; DRUG STRUCTURE; ENVIRONMENTAL EXPOSURE; GENERAL ANESTHESIA; HUMAN; IMMUNOGLOBULIN PRODUCTION; INCIDENCE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NORWAY; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; SWEDEN;

ALLERGENS; ANESTHESIA, GENERAL; CODEINE; COUGH; DRUG HYPERSENSITIVITY; DRUG INDUSTRY; EPITOPES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INCIDENCE; MODELS, IMMUNOLOGICAL; MORPHOLINES; NEUROMUSCULAR BLOCKING AGENTS; NORWAY; PRODUCT SURVEILLANCE, POSTMARKETING; SWEDEN;

EID: 67649231549     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.04.002     Document Type: Review

References (13)

1. Mertes P.-M., and Laxenaire M.C. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep 4 (2004) 7-17
2. Currie M., Webb R.K., Williamson J.A., et al. The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 21 (1993) 621-625
3. Mitsuhata H., Matsumoto S., and Hasegawa J. The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui 41 (1992) 1664-1669
4. Axon A.D., and Hunter J.M. Editorial III: anaphylaxis and anaesthesia- all clear now?. Br J Anaesth 93 (2004) 501-504
5. Baldo B.A., and Fisher M.M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 306 (1983) 262-264
6. Fisher M.M., and Baldo B.A. Immunoassays for the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 28 (2000) 167-170
7. Laake J.H., and Røttingen J.-A. Rocoronium and anaphylaxis-a statistical challenge. Acta Anaesthesiol Scand 45 (2001) 1196-1203
8. Harboe T., Guttormsen A.B., Irgens A., et al. Anaphylaxis during anaesthesia in Norway. A six-year single centre study. Anesthesiology 102 (2005) 897-903
9. Harboe T., Johansson S.G.O., Florvaag E., et al. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 62 (2007) 1445-1450
10. Florvaag E., Johansson S.G.O., Öman H., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidence of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 49 (2005) 437-444
11. Chen Z.R., Bochner F., and Somogyi A. Pharmacokinetics of pholcodine in healthy volunteers: single and chronic dosing studies. Br J clin Pharmacol 26 (1988) 445-453
12. Florvaag E., Johansson S.G.O., Öman H., et al. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study. Allergy 61 (2006) 49-55
13. Johansson S.G.O., Öman H., Nopp A., et al. Pholcodine caused anaphylaxis in Sweden 30-years ago. Allergy 64 (2009) 820-821